Please login to the form below

Not currently logged in
Email:
Password:

early asset development

This page shows the latest early asset development news and features for those working in and with pharma, biotech and healthcare.

Redefining launch excellence in 2017

Redefining launch excellence in 2017

Now, more so than ever, launch preparation and commercial involvement should begin as early as possible in the asset’s development. ... It is crucial that these teams connect as early as possible, because whether it is intentional or not, the

Latest news

  • Cello Health expands with Defined Health acquisition Cello Health expands with Defined Health acquisition

    Defined Health will work closely with its new parent company in early asset development and commercialisation, with a particular focus on defining value for early-stage compounds. ... offer our clients through the full span of the development process

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Assessing early market opportunity Assessing early market opportunity

    To successfully develop and launch an asset it’s crucial to identify and define the commercial value early in the process. ... On the 19. th. April Cello Health, in association with PMGroup, will host a free webinar which will discuss the background

  • Managing value: Why early asset development and commercialisation are important Managing value: Why early asset development and commercialisation are important

    Managing value: Why early asset development and commercialisation are important. Realising the full value of your asset - clinically and commercially - means thinking beyond the pure scientific value, even at the very ... Unsurprisingly, slightly more

  • The value of early asset development and commercialisation The value of early asset development and commercialisation

    On July 13 Cello Health, in association with PMGroup, will host a free webinar on the value of early asset development and commercialisation. ... It will follow the asset development journey, defining value from both a financial and clinical perspective,

More from intelligence
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics